News Story Video

UH Neurologist and Neurosurgeon Discuss John McCain Brain Tumor (VIDEO/AUDIO)




CLEVELAND -- Neurologist Michael De Georgia, MD, Director of the Neurocritical Care Center at University Hospitals Cleveland Medical Center, and Andrew Sloan, MD, neurosurgeon at University Hosptials Cleveland Medical Center, discusses John McCain's diagnosis of glioblastoma.


While Mother Battles Brain Cancer, Maria Menounos Reveals She Had Brain Tumor Removed (VIDEO)




CLEVELAND -- Maria Menounos will step down from E! News after she had a golf ball-sized brain tumor removed last month. The 39-year-old received the diagnosis in April after complaining of symptoms including blurred vision and slurred speech.

"For Maria, this sounds like meningioma," says Jennifer Sweet, MD, a neurosurgeon at University Hospitals Cleveland Medical Center. "These are usually benign tumors."

This news comes as Maria's mother Litsa is battling stage 4 brain cancer but hers is a more malignant glioma.

"There doesn't seem to be any correlation between the two and a hereditary pattern is very unlikely," says Dr. Sweet.

Meningioma is a slow-growing tumor that appears more in women than men and which can sometimes take a while to detect since the brain can adapt to their size until they grow large enough to cause symptoms. They can be treated either by monitoring or, when necessary, through surgery or radiation. 

"They tend to have a very good prognosis," says Dr. Sweet. "For the most part, patients do very well and can have very long, healthy lives."


Mechanical retrieval of brain clots dramatically better for stroke than medical treatment alone, DAWN trial confirms (VIDEO/AUDIO)




CLEVELAND -- "This is really exciting for all of us," says Cathy Sila, MD, Director of the Comprehensive Stroke Center at University Hospitals Cleveland Medical Center. "When this treatment works the way it's supposed to and works for the right patient, it really is a miracle."

Dr. Sila is talking about the results of the DAWN Trial, which studied one set of patients treated medically and another set treated by using advance neuroimaging followed by mechanical retrieval of the brain clot.

"There was a dramatic difference in the outcome between the two arms," Dr. Sila says. "Almost half of the patients (48.6%) who received the stent retriever device had a good outcome after three months after their stroke as opposed to only thirteen (13.1%) percent who were treated medically," Dr. Sila says.

The results proved so dramatic the trial was stopped after two years and 200 patients instead of the designed 500 patients. Dr. Sila says the advanced neuroimaging is a better indicator of who can benefit from clot busting than the amount of time after the stroke (last known well). She says previously 30 to 40 percent of patients didn't qualify.

"The procedure and the device itself has an upfront cost but, when you think that the vast majority of stroke care costs are in the lost ability to go back to work, the nursing home stays, the rehabilitation costs, and just the human costs of not being able to do what they did before."

UH Cleveland Medical Center was one of the sites for this multi-center global trail. The study was supported by Stryker, which produces the Trevo Retriever, a tiny stent-shaped medical device that is attached to a thin wire.


UH Discover the Difference Campaign Celebrates Reaching $1.5 Billion Goal (VIDEO)




CLEVELAND – University Hospitals (UH) has achieved its Discover the Difference: The Campaign for University Hospitals goal of $1.5 billion. This milestone represents the culmination of a multi-year effort made possible through the generosity of more than 83,500 donors – including individuals, corporations, foundations and government support – contributing nearly 185,000 gifts. Donor support ranged from $1 to $72.6 million. The final amount donated to the historic campaign: $1,511,586,803.

“The extraordinary success of the Discover the Difference campaign is a tribute to the enduring philanthropic spirit upon which University Hospitals was founded 151 years ago,” says Thomas F. Zenty III, CEO, University Hospitals. “The generosity of our community and continuous commitment to excellence paved the way to an unprecedented transformation into one of the top health care delivery systems in the nation.”

UH publically launched Discover the Difference: The Campaign for University Hospitals in 2010 with a goal of $1 billion. After community support far exceeded expectations, in 2012 the goal was increased to $1.5 billion. UH is the second health system in the country, and the only in Ohio, to accomplish such an ambitious campaign goal.

The campaign has been used to enhance and expand clinical care programs, establish new endowed funds, and complete capital projects including those identified in the Vision 2010 strategic plan: UH Ahuja Medical Center; UH Seidman Cancer Center; Center for Emergency Medicine and Marcy R. Horvitz Pediatric Emergency Center; and the Quentin & Elisabeth Alexander Neonatal Intensive Care Unit. 

University Hospitals will hold a gala to thank its donors Saturday, May 13 at the Hilton Cleveland (100 Lakeside Avenue, Cleveland, Ohio). A reception begins at 6:30 p.m. and program begins at 8:30 p.m.


Oral immunotherapy could be cure for peanut-allergic kids (VIDEO/AUDIO)




CLEVELAND -- Five-year-old Adam Schenker has been severely allergic to peanuts since he was 13 months old. So much so that even touching a surface area exposed to peanuts would cause him to break out in hives. Since November 2016, Eli Silver, MD, Allergist at UH Rainbow Babies & Children’s has been treating Adam with oral immunotherapy for his peanut allergies. This approach consists of giving peanut-allergic children very tiny amounts of peanut allergen as directed by a doctor. Over time, these small amounts of the allergen are thought to lessen the body's reaction to it. And that’s exactly what it’s doing for Adam. Recently, Adam was able to eat his first whole peanut, without experiencing any allergic reaction, just four months after treatment.
 
This type of therapy is in line with new guidelines out earlier this year by the National Institute of Allergy and Infectious Diseases recommending parents give their children foods containing peanuts early and often, starting when they’re infants, as a way to help avoid life-threatening peanut allergies. Additionally, children with food allergies are two to four times more likely to have other related conditions including asthma and other allergies.

"It's really a constant every day risk," says Wendy Hanna, Adam's mother. "And so to be able to remove that I literally feel like it's life-saving because it's reducing this thing that's potentially lethal and is everywhere."

 




You must be logged in to view this item.



Login

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.